A Novel RNA Transcript with Antiapoptotic Function Is Silenced in Fragile X Syndrome
2008

FMR4: A New RNA Linked to Fragile X Syndrome

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Khalil Ahmad M. Faghihi, Mohammad Ali Modarresi, Farzaneh Brothers, Shaun P. Wahlestedt, Claes Wahlestedt

Primary Institution: The Scripps Research Institute

Hypothesis

Does the noncoding RNA FMR4 have an antiapoptotic function and is it affected by the CGG expansion in the FMR1 gene associated with fragile X syndrome?

Conclusion

FMR4 has an antiapoptotic function and is silenced in fragile X syndrome, suggesting its potential role in the disease's clinical presentation.

Supporting Evidence

  • FMR4 is expressed in several human adult tissues including the brain, liver, and heart.
  • Knockdown of FMR4 led to increased apoptosis in human cells.
  • FMR4 expression is silenced in full mutation fragile X patients.

Takeaway

Scientists found a new RNA called FMR4 that helps cells stay alive, and it doesn't work properly in people with fragile X syndrome.

Methodology

The study used genomic approaches including RT-PCR and siRNA knockdown experiments to analyze FMR4 expression and function.

Potential Biases

Potential bias in sample selection and the focus on specific tissues may affect the generalizability of the findings.

Limitations

The study primarily focused on human and monkey tissues, limiting the understanding of FMR4's role in other species.

Participant Demographics

The study included samples from normal individuals, premutation carriers, and full mutation fragile X patients.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pone.0001486

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication